KYNBKYNTRA BIO, INC.同业对比
KYNTRA BIO, INC. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KYNB本股 | $18M#8 | 0.1x#1 | — | 2.8x#2 | -78.3%#6 | 485.6%#2 | -712.7%#6 | — | — | — | -58.2%#1 | — |
| ATOS | $23M#1 | — | 0.8x#5 | 12885.7x#9 | -95.6%#7 | -36.3%#12 | -2112684.9%#9 | -129.6%#10 | — | — | — | — |
| MIRA | $21M#2 | — | 2.6x#9 | — | — | -33.0%#10 | — | -127.9%#9 | — | — | — | — |
| ELAB | $19M#6 | — | 1.1x#6 | 32.2x#8 | — | -24.0%#9 | -1304.4%#7 | -46.3%#4 | — | — | -99.8%#4 | — |
| AYTU | $21M#3 | — | 0.6x#3 | 0.4x#1 | -13.3%#3 | -5.1%#7 | -14.4%#1 | -40.5%#3 | -43.8%#3 | 4#2 | — | — |
| TXMD | $21M#4 | — | 0.8x#4 | 6.9x#4 | 71.6%#1 | 73.9%#3 | -145.3%#2 | -2.1%#2 | -3.8%#1 | 5#1 | — | — |
| COCP | $19M#5 | — | 18.5x#11 | 9.6x#5 | -69.3%#5 | 49.5%#4 | -447.8%#4 | -845.9%#11 | -20.4%#2 | 3#3 | — | — |
| IGC | $19M#7 | — | 3.1x#10 | 14.8x#6 | -5.5%#2 | 45.2%#5 | -585.8%#5 | -116.1%#8 | -125.5%#5 | 3#3 | — | — |
| MCRB | $17M#9 | — | 0.5x#2 | 22.2x#7 | — | 4088.2%#1 | -11910.1%#8 | 16.5%#1 | -72.9%#4 | — | -88.8%#2 | — |
| CNTX | $17M#10 | — | 0.5x#1 | — | — | -35.2%#11 | — | -94.6%#6 | — | — | — | — |
| MRKR | $16M#11 | — | 1.3x#7 | 4.6x#3 | -46.2%#4 | -13.3%#8 | -363.5%#3 | -100.0%#7 | -1413.6%#6 | — | — | — |
| REVB | $16M#12 | 0.1x#2 | 1.6x#8 | — | — | 40.7%#6 | — | -88.5%#5 | — | — | -88.9%#3 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-11-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议